These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21033493)

  • 1. [Non-medical therapy in heart failure: instrumental treatment and cardiac transplantation].
    Leprince P
    Rev Prat; 2010 Sep; 60(7):951-4. PubMed ID: 21033493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent mechanical circulatory support in patients of advanced age.
    Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a continuous-flow device in patients awaiting heart transplantation.
    Miller LW; Pagani FD; Russell SD; John R; Boyle AJ; Aaronson KD; Conte JV; Naka Y; Mancini D; Delgado RM; MacGillivray TE; Farrar DJ; Frazier OH;
    N Engl J Med; 2007 Aug; 357(9):885-96. PubMed ID: 17761592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destination therapy: time for real progress.
    Westaby S
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):477-83. PubMed ID: 18560406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What's new in mechanical circulatory assistance: from clinical indications to material].
    Pavie A; Leprince P; Bonnet N; Leger P; Gandjbakhch I
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):164-70. PubMed ID: 16555700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure. A new milestone for a better life.
    Agati S; Vitali E; DeBakey ME
    Minerva Cardioangiol; 2003 Apr; 51(2):215-26. PubMed ID: 12783077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridge to transplant experience: factors influencing survival to and after cardiac transplant.
    Smedira NG; Hoercher KJ; Yoon DY; Rajeswaran J; Klingman L; Starling RC; Blackstone EH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1295-305, 1305.e1-4. PubMed ID: 20412961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure.
    Korewicki J
    Cardiol J; 2009; 16(6):493-9. PubMed ID: 19950084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.